Cancer Diagnosis
What is Cancer Diagnosis?
Cancer diagnosis research aims to develop improved technologies and techniques for detecting and characterizing cancer, determining its stage, selecting appropriate treatments, and monitoring patient outcomes. Major areas of focus include discovering and validating diagnostic, prognostic, and predictive biomarkers; improving imaging and molecular profiling to define tumor characteristics; and advancing integrated diagnosis systems to enable precision oncology.
Accurate diagnosis across all cancer phases, from risk assessment through early detection, localized disease, and late-stage progression, provides vital information guiding timely intervention and optimal care for better outcomes. Ongoing diagnosis monitoring also gives critical insight into treatment efficacy and disease recurrence.
NFCR IMPACTS IN CANCER DIAGNOSIS
- NFCR provides funding for research correlating novel diagnostic markers with tumor biology and treatment outcomes, expanding cancer characterization for better-informed care.
- NFCR supports studies integrating imaging with genomics, proteomics, and metabolomics to advance diagnostics for localized and recurrent tumors.
- Through its seed grant initiatives, NFCR enables proof-of-concept studies on early-stage diagnostic technologies to accelerate development into clinical tools.
NFCR-Supported Researchers Working on Cancer Diagnosis

Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital

Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital

Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital

Aaron N. Hata, M.D., Ph.D.
Harvard Medical School and Massachusetts General Hospital
Related Content
[vc_template name=”A world without”]
A world without cancer is possible. Help us turn lab breakthroughs into life-saving realities.

5.7 Million+
Donors who have fueled NFCR’s mission

$420 Million+
Invested in high-impact research & programs

36+ Labs & Hundreds of
Nobel Laureates & Key Scientists received NFCR funding, driving breakthrough research












